Enzo Biochem(ENZ) - 2023 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-09974 ENZO BIOCHEM, INC. (Exact name of registrant as specified in its charter) FORM 10-K New York 13-2866202 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 81 Executive Blvd. Suite 3 (Mark one) ☒ ANNUAL REP ...